How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

GR

MAD:Grifols
Get a brief AI stock analysisSaves ~ 15 minutes of your time

GR

Grifols SAMAD Grifols Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XMAD - Bolsa de Madrid

FAIR VALUE

Is GRF undervalued compared to its fair value?

The fair value of GRF stock is hidden EUR. Relative to the market price of 9.246 EUR Grifols SA is hidden.

Grifols SA engages in the production of plasma derivatives. The company is headquartered in Barcelona, Barcelona and currently employs 23,245 full-time employees. The company went IPO on 2006-05-17. The company organizes...[More about valuation]

Grifols SA Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

6.291 $B

Price:

9.246 EUR

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.082

FINANCIALS

Grifols SA financial for reporting period

Income Statement

1.8 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.056 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

1.8 B 100%
0.69 B 39%
0.056 B 3%

Balance Sheet

21.4 B
5.8 B

Financial Position Analysis

Assets

21.4 B
Current Assets
6.5 B
Total non-current assets
15 B

Total current liabilities
2.3 B
Total non-current liabilities
13.3 B

Cash Flow Statement

0.23 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.16 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Grifols SA fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is GRF attractive for investment based on fundamental analysis?

GRF stock rating is hidden. Grifols SA is a hidden by Eyestock methodology.

Get GRF Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

GRF.MC analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for GRF.MC to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Grifols SA competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Grifols SA dividends

Grifols SA dividend yield is 2.36%

The annual dividend is 0.53 EUR

GRF.MC dividend metrics

Payout ratio
64.07%
Dividend yield
2.36%
Annual dividend
0.53
Dividend streak
8 years
Average dividend yield over 3 years
1.90%
Average dividend yield over 5 years
1.81%

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About GRF.MC stock

About the company Grifols SA

Market cap $B

6.291

Dividend yield

2.36 %

Shares outstanding

678.410786 B

Grifols SA engages in the production of plasma derivatives. The company is headquartered in Barcelona, Barcelona and currently employs 23,245 full-time employees. The company went IPO on 2006-05-17. The company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.

GRF.MC profile

  • Ticker

    GRF.MC

  • Country

    Spain

  • Exchange

    XMAD - Bolsa de Madrid

  • Report currency

    EUR - Euro

  • IPO date

    17 May 2006

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    23245

  • City

    Barcelona

  • Address

    C/ Jesus y Maria, 6

  • Cusip

    E5706X215